484 related articles for article (PubMed ID: 21449851)
1. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.
Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH
Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851
[TBL] [Abstract][Full Text] [Related]
2. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
3. Anatomic and functional outcome after surgical removal of idiopathic macular epiretinal membrane.
Lee PY; Cheng KC; Wu WC
Kaohsiung J Med Sci; 2011 Jul; 27(7):268-75. PubMed ID: 21757144
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane.
Ahn JH; Park HJ; Lee JE; Oum BS
Retina; 2012 May; 32(5):892-6. PubMed ID: 22252232
[TBL] [Abstract][Full Text] [Related]
5. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
7. Triamcinolone in small-gauge vitrectomy for epiretinal membrane peeling.
Angermann R; Zehetner C; Sidoroff P; Waltl I; Kieselbach G; Kralinger M
Can J Ophthalmol; 2018 Dec; 53(6):632-636. PubMed ID: 30502990
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
9. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane.
Kim J; Rhee KM; Woo SJ; Yu YS; Chung H; Park KH
Am J Ophthalmol; 2010 Nov; 150(5):701-709.e1. PubMed ID: 20719296
[TBL] [Abstract][Full Text] [Related]
10. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.
Suh MH; Seo JM; Park KH; Yu HG
Am J Ophthalmol; 2009 Mar; 147(3):473-480.e3. PubMed ID: 19054492
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
12. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis.
Zheng B; Chen Y; Chen Y; Zhao Z; Zhang Z; Zheng J; You Y; Wang Q; Shen L
Retina; 2011 Apr; 31(4):692-701. PubMed ID: 21836401
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Horozoglu F; Celik E; Nohutcu AF
Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of macular thickness and function before and after idiopathic macular epiretinal membrane surgery].
Zhou J; Liu W; Li Q; Li X; Hao J; Wang XL
Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):119-23. PubMed ID: 22490946
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone acetonide as an adjuvant to membrane peeling surgery: a pilot study.
Paspulati A; Punjabi OS; Theodoropoulou S; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):41-5. PubMed ID: 23418733
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcome after removal of idiopathic macular epiretinal membrane in young patients.
Fang X; Chen Z; Weng Y; Shu Z; Ni H; Jiang J; Yao K
Eye (Lond); 2008 Nov; 22(11):1430-5. PubMed ID: 17767144
[TBL] [Abstract][Full Text] [Related]
18. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
19. Anatomical and visual outcome after vitrectomy with triamcinolone acedonide-assisted epiretinal membrane removal in highly myopic eyes with retinal detachment due to macular hole.
Fang X; Zheng X; Weng Y; Chen Z; Liu J; Chen B; Wu P; Ni H; Yao K
Eye (Lond); 2009 Feb; 23(2):248-54. PubMed ID: 18344953
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Bardak Y; Cekiç O; Tiğ SU
Eye (Lond); 2006 Dec; 20(12):1357-9. PubMed ID: 16294204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
